Tyk2 and Stat3 regulate brown adipose tissue differentiation and obesity

Marta Derecka1, Agnieszka Gornicka, Sergei B Koralov

  • 1Department of Biochemistry and Molecular Biology and Massey Cancer Center, Virginia Commonwealth University, Richmond, VA 23298, USA.

Cell Metabolism
|December 11, 2012
PubMed

Insights

Mice lacking Tyrosine Kinase 2 (Tyk2) develop obesity due to impaired brown fat development. Restoring Tyk2 or Stat3 function improved brown adipose tissue (BAT) development and reduced obesity.

Area of Science:

  • Biochemistry
  • Cell Biology
  • Obesity Research

Background:

  • Tyk2 (Tyrosine Kinase 2) is a JAK tyrosine kinase.
  • Brown adipose tissue (BAT) plays a crucial role in energy expenditure and thermogenesis.
  • Aberrant BAT development is linked to obesity.

Purpose of the Study:

  • To investigate the role of Tyk2 in brown adipose tissue (BAT) development.
  • To explore the relationship between Tyk2, Stat3, and BAT differentiation.
  • To identify potential therapeutic targets for obesity.

Main Methods:

  • Generation and analysis of Tyk2-deficient mice.
  • High-fat diet feeding studies.
  • Analysis of gene expression and protein stability.
  • Studies involving Stat3 activation and PRDM16 interaction.

Main Results:

  • Tyk2 deficiency leads to progressive obesity and impaired Myf5+ BAT development in mice.
  • Tyk2 RNA levels are decreased in BAT and skeletal muscle of mice on high-fat diets and in obese humans.
  • Restoration of Tyk2 or Stat3 (Signal Transducer and Activator of Transcription 3) function in Tyk2(-/-) brown preadipocytes improved differentiation.
  • CAStat3 (constitutively active Stat3) expression in BAT of Tyk2(-/-) mice improved BAT development, insulin levels, and reduced body weight.
  • Stat3 binds to and enhances the stability of PRDM16, a key regulator of BAT differentiation.

Conclusions:

  • Tyk2 and Stat3 are critical determinants of brown fat lineage.
  • Altered Tyk2 levels are associated with obesity in both rodents and humans.
  • Targeting the Tyk2-Stat3-PRDM16 pathway may offer a therapeutic strategy for obesity.

Related Concept Videos

The JAK-STAT Signaling Pathway01:20

The JAK-STAT Signaling Pathway

Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as  SH2...
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a rapamycin-insensitive companion...
Master Transcription Regulators02:23

Master Transcription Regulators

Master transcription regulators are regulatory proteins that are predominantly responsible for regulating the expression of multiple genes. Often these genes work in concert to drive a  complex process. Activation of a master transcription regulator can lead to a cascade of transcriptional activation necessary for that outcome. These regulators can directly bind to the regulatory sequences of the various genes involved, or they can indirectly regulate transcription by binding to regulatory...
TGF - β Signaling Pathway01:16

TGF - β Signaling Pathway

The TGF-β signaling pathway regulates cell growth, differentiation, adhesion, motility, and development. TGF-β ligands that induce TGF-β signaling are synthesized in their latent form. Several proteases or cell surface receptors such as integrins act upon the latent form, releasing the active ligand. There are three types of mammalian TGF-βs: (TGF-β1, TGF-β2, and TGF-β3) that bind as homodimers or heterodimers to TGF-β receptors. The TGF-β receptors are of three kinds RI, RII, and RIII. The RI...
Type II Diabetes I: Introduction01:26

Type II Diabetes I: Introduction

Type 2 diabetes mellitus (T2DM) is a chronic metabolic disorder characterized by insulin resistance, in which target tissues such as the liver, muscle, and adipose tissue respond poorly to insulin. It is also associated with inadequate compensatory insulin secretion, where pancreatic β-cells fail to produce sufficient insulin. Together, these abnormalities lead to persistent hyperglycemia.EtiologyT2DM develops through a complex interaction of genetic predisposition and environmental or...